NCT02299700 (Mentis) is a clinical trial of No Intervention in Autism Spectrum Disorder, sponsored by Janssen Research & Development, LLC.

Who is sponsoring NCT02299700?

NCT02299700 is sponsored by Janssen Research & Development, LLC.

What drugs are being tested in NCT02299700?

Interventions in NCT02299700: No Intervention.

What condition does NCT02299700 study?

NCT02299700 studies Autism Spectrum Disorder.

Is NCT02299700 still recruiting?

NCT02299700 is currently completed. Last updated 23 October 2017.

Last reviewed 2017-10-23 · How we verify

NCT02299700: Mentis

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study to Evaluate the Janssen Autism Knowledge Engine in Children and Adults With Autism Spectrum Disorder

Completed Last updated 23 October 2017

What this trial tests

trial testing No Intervention in Autism Spectrum Disorder in 34 participants. Completed in 24 April 2015.

Timeline

30 September 2014

Primary endpoint
24 April 2015

24 April 2015

Quick facts

Lead sponsor	Janssen Research & Development, LLC
Status	Completed
Study type	OBSERVATIONAL
Enrollment	34
Start date	30 September 2014
Primary completion	24 April 2015
Estimated completion	24 April 2015
Sites	3 locations across United States

Drugs / interventions tested

No Intervention

Conditions studied

Autism Spectrum Disorder — all drugs for Autism Spectrum Disorder →

Sponsor

Janssen Research & Development, LLC — full company profile →

Who can join

3 and older, any sex, with Autism Spectrum Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to assess the usability of the Janssen Autism Knowledge Engine (JAKE) as a system to monitor clinical outcomes in autism spectrum disorder (ASD) (severe abnormalities in the development of many basic psychological functions that are not normal for any stage in development. These abnormalities are manifested in sustained social impairment, speech abnormalities, and peculiar motor movements).

Publications & conference data

8 peer-reviewed publications reference this trial (live from Europe PMC):

Relationship Between Sleep and Behavior in Autism Spectrum Disorder: Exploring the Impact of Sleep Variability.
Bangerter A, Chatterjee M, Manyakov NV, Ness S, et al · · 2020 · cited 43× · PMID 32265629 · DOI 10.3389/fnins.2020.00211
Autism Behavior Inventory: A Novel Tool for Assessing Core and Associated Symptoms of Autism Spectrum Disorder.
Bangerter A, Ness S, Aman MG, Esbensen AJ, et al · · 2017 · cited 35× · PMID 28498053 · DOI 10.1089/cap.2017.0018
Automatic Recognition of Posed Facial Expression of Emotion in Individuals with Autism Spectrum Disorder.
Manfredonia J, Bangerter A, Manyakov NV, Ness S, et al · · 2019 · cited 33× · PMID 30298462 · DOI 10.1007/s10803-018-3757-9
JAKE® Multimodal Data Capture System: Insights from an Observational Study of Autism Spectrum Disorder.
Ness SL, Manyakov NV, Bangerter A, Lewin D, et al · · 2017 · cited 26× · PMID 29018317 · DOI 10.3389/fnins.2017.00517
Visual Exploration in Autism Spectrum Disorder: Exploring Age Differences and Dynamic Features Using Recurrence Quantification Analysis.
Manyakov NV, Bangerter A, Chatterjee M, Mason L, et al · · 2018 · cited 24× · PMID 30273450 · DOI 10.1002/aur.2021
Automated recognition of spontaneous facial expression in individuals with autism spectrum disorder: parsing response variability.
Bangerter A, Chatterjee M, Manfredonia J, Manyakov NV, et al · · 2020 · cited 19× · PMID 32393350 · DOI 10.1186/s13229-020-00327-4
Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder.
Bangerter A, Ness S, Lewin D, Aman MG, et al · · 2020 · cited 13× · PMID 30888551 · DOI 10.1007/s10803-019-03965-7
Learning Scan Paths of Eye Movement in Autism Spectrum Disorder.
Chatterjee M, Manyakov NV, Bangerter A, Kaliukhovich DA, et al · · 2020 · cited 3× · PMID 32570392 · DOI 10.3233/shti200168

Verify or expand the search:

Other trials of No Intervention

Trials testing the same drug.

NCT07353099 — A Study in Children and, Adults With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Treated With Adzynma · not yet recruiting
NCT07429942 — A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Recei · not yet recruiting
NCT07521917 — Child Abuse and Neglect Awareness Training in Nursing Students · NA · not yet recruiting
NCT07319832 — A Study of Teduglutide in Chinese Children and Teenagers With Short Bowel Syndrome · recruiting
NCT07425574 — A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults · recruiting

Other recruiting trials for Autism Spectrum Disorder

Currently open trials in the same condition.

NCT07324057 — The Effects of Preoperative Intranasal Administration of Dexmedetomidine and Esketamine on Negative Postoperative Behavi · NA · recruiting
NCT07493096 — Intensive Multimodal Neurorehabilitation Targeting Neuroplasticity in Pediatric Neurodevelopmental and Chromosomal Disor · recruiting
NCT07505290 — Efficacy of the Korean PEERS® for Preschoolers (PEERS®-PS-K) Social Skills Intervention: A Randomized Controlled Trial f · NA · active not recruiting
NCT07524192 — A Self-Instructional Online Program for Early Childhood and Elementary Teachers Supporting Autistic Children and Childre · NA · recruiting
NCT07432776 — Effect of an 8-Week Pickleball Program for Adults With Autism: A Feasibility Trial With a Delayed-Control Design · EARLY_PHASE1 · recruiting

Other Janssen Research & Development, LLC trials

Trials by the same sponsor.

NCT07518186 — A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma · Phase 3 · not yet recruiting
NCT07309445 — A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC · recruiting
NCT07499232 — A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease · Phase 3 · not yet recruiting
NCT07438496 — A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus · Phase 3 · recruiting
NCT07227025 — A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02299700 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Janssen Research & Development, LLC
Last refreshed: 23 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02299700.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing